Recent advances in SCF ubiquitin ligase complex: Clinical implications

被引:81
|
作者
Zheng, Nana [1 ,2 ]
Zhou, Quansheng [1 ,2 ]
Wang, Zhiwei [1 ,2 ,3 ]
Wei, Wenyi [3 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Collaborat Innovat Ctr Hematol, Suzhou 215123, Peoples R China
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA
来源
基金
中国国家自然科学基金;
关键词
F-box protein; Ubiquitin; Tumor suppressor; Oncoprotein; Human cancer; F-BOX PROTEIN; CELL-CYCLE ARREST; NF-KAPPA-B; PHOSPHORYLATION-DEPENDENT UBIQUITINATION; TUMOR-SUPPRESSOR FUNCTIONS; TRCP-MEDIATED DEGRADATION; TRAIL-INDUCED APOPTOSIS; PROSTATE-CANCER CELLS; MOUSE C-MYB; BETA-TRCP;
D O I
10.1016/j.bbcan.2016.05.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
F-box proteins, which are subunit recruiting modules of SCF (SKP1-Cullin 1-F-box protein) E3 ligase complexes, play critical roles in the development and progression of human malignancies through governing multiple cellular processes including cell proliferation, apoptosis, invasion and metastasis. Moreover, there are emerging studies that lead to the development of F-box proteins inhibitors with promising therapeutic potential. In this article, we describe how F-box proteins including but not restricted to well-established Fbw7, Skp2 and beta-TRCP, are involved in tumorigenesis. However, in-depth investigation is required to further explore the mechanism and the physiological contribution of undetermined F-box proteins in carcinogenesis. Lastly, we suggest that targeting F-box proteins could possibly open new avenues for the treatment and prevention of human cancers. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:12 / 22
页数:11
相关论文
共 50 条
  • [11] The SCF ubiquitin ligase: Insights into a molecular machine
    Cardozo, T
    Pagano, M
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (09) : 739 - 751
  • [12] Cell cycle control by the SCF ubiquitin ligase
    Harper, JW
    Koepp, D
    Ye, X
    Jin, JP
    Elledge, SJ
    FASEB JOURNAL, 2002, 16 (05): : A740 - A740
  • [13] The SCF ubiquitin ligase: insights into a molecular machine
    Timothy Cardozo
    Michele Pagano
    Nature Reviews Molecular Cell Biology, 2004, 5 : 739 - 751
  • [14] Identification of an SCF Ubiquitin Ligase Complex that Contributes to Resistance Against Valsa Canker in Apple
    Han, Pengliang
    Zhang, Ruotong
    Li, Rui
    Li, Fudong
    Huang, Lili
    MOLECULAR PLANT-MICROBE INTERACTIONS, 2024, 37 (06) : 520 - 529
  • [15] Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase
    Kamura, T
    Koepp, DM
    Conrad, MN
    Skowyra, D
    Moreland, RJ
    Iliopoulos, O
    Lane, WS
    Kaelin, WG
    Elledge, SJ
    Conaway, RC
    Harper, JW
    Conway, JW
    SCIENCE, 1999, 284 (5414) : 657 - 661
  • [16] Identification of an SCF ubiquitin-ligase complex required for auxin response in Arabidopsis thaliana
    Gray, WM
    del Pozo, JC
    Walker, L
    Hobbie, L
    Risseeuw, E
    Banks, T
    Crosby, WL
    Yang, M
    Ma, H
    Estelle, M
    GENES & DEVELOPMENT, 1999, 13 (13) : 1678 - 1691
  • [17] The SCF ubiquitin ligase in cell cycle control and beyond
    Skowyra, D
    Winston, J
    Chu, C
    Durand, B
    Keoppe, D
    Elledge, SJ
    Harper, JW
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 240A - 240A
  • [18] Druggability of SCF ubiquitin ligase-protein interfaces
    Cardozo, T
    Abagyan, R
    UBIQUITIN AND PROTEIN DEGRADATION, PT B, 2005, 399 : 634 - +
  • [19] Form and function of SCF ubiquitin protein ligase complexes
    Tyers, MD
    FASEB JOURNAL, 1999, 13 (07): : A1513 - A1513
  • [20] Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase
    Tintignac, LA
    Lagirand, J
    Batonnet, S
    Sirri, V
    Leibovitch, MP
    Leibovitch, SA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (04) : 2847 - 2856